KKR has acquired a majority stake in HealthCare Royalty Partners, pushing the investment firm further into the healthcare ...

Investment firm KKR (NYSE:KKR) announced on Wednesday the acquisition of a majority stake in biopharma royalty acquisition company, HealthCare Royalty Partners. The acquisition marks KKR's expansion ...

KKR executives said strong momentum in their business gave them confidence on Thursday of beating earnings targets for 2026, ...

KKR & Co. Inc., a leading global investment firm, today announced that it has acquired a majority ownership stake in HealthCare Royalty Partners (HCRx), a leading biopharma royalty acquisition company ...

HealthCare Royalty Partners, a private equity firm that invests in drug royalties and other health care-related investments, has rounded up $1.02 billion for its third fund, according to a filing ...

HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States in exchange for future hyperphosphatemia royalty payments from Ardelyx Japanese collaboration partner.

Contacts HealthCare Royalty Partners Carlos Almodovar, 203-487-8311 [email protected] ...

HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from Ardelyx Japanese collaboration ...

4 March 2014 A - A + 100% Invuity, which develops medical devices, has raised $36 million in a Series E funding round led by HealthCare Royalty Partners. Additional investors in the round include ...

Clarke Futch, co-founder and managing partner of health care investment firm HealthCare Royalty Partners, poses for a photo inside his office at 300 Atlantic St., in downtown Stamford, Conn., on ...

Publicly traded pharmaceutical company Adamas Pharmaceuticals Inc. said it entered into a $100 million royalty-backed note agreement with HealthCare Royalty Partners. Adamas in a press release ...